MERIDIAN
Sector

Healthcare

60 deals tracked in Healthcare.

LevFinSIGNED

Atrys Health Agrees Eight Million Euro Loan with Inveready CEO

Healthcare services technology company Atrys Health has agreed an eight million euro loan with the CEO of Inveready to address the maturity of its convertible n…

12 Nov 2026
ECMCLOSED

Spanish Biotech Votum Labs Raises 1.2 Million Euros in Pre-Series A Round

Spanish biotechnology company Votum Labs has raised 1.2 million euros in a pre-series A round to drive its international expansion and commercial growth. The co…

€1.2M12 Nov 2026
LevFinSIGNED

Private Credit Lenders in Talks to Provide $1.3bn for L Catterton's Fullscript Buyout

A consortium of private credit lenders is in discussions to provide $1.3bn in financing for L Catterton's acquisition of healthcare technology platform Fullscri…

$1.3Bn10 Nov 2026
LevFinRUMOURED

Wall Street Banks Prepare $3.1bn Debt Financing for CD&R and McKesson's Option Care Deal

Goldman Sachs, Bank of America, and Barclays are preparing a $3.1bn debt financing package. The facility is designed to support Clayton, Dubilier & Rice (CD&R) …

$3.1Bn6 Nov 2026
M&ACLOSED

Kos Biotechnology Partners Backs Fathom Therapeutics

Kos Biotechnology Partners has completed an investment in Fathom Therapeutics to support its AI-driven drug discovery platform. Kos joins existing backers inclu…

6 Nov 2026
RestructuringRUMOURED

CVS Health Moves to Dismantle $117 Billion Healthcare Empire

CVS Health is moving to dismantle its $117bn healthcare empire through a potential spin-off of its drugstore business. The strategic pivot comes as political pr…

$117.0Bn3 Nov 2026
M&ASIGNED

Cinven to acquire Theramex for €2.6bn from Carlyle and PAI Partners

Cinven has agreed to buy women's health and menopause specialist Theramex from Carlyle and PAI Partners for €2.6bn. The transaction values the business at more …

€2.6Bn3 Nov 2026
LevFinSIGNED

EIB Provides €40 Million Financing to Impress for AI Platform Scaling

The European Investment Bank is financing Impress with 40 million euros to scale its clinical AI platform. The funding initiative forms part of the EIB Group's …

28 Oct 2026
ECMCLOSED

Vera Health Raises 25.5 Million for Clinical AI Platform

Vera Health has raised 25.5 million in a funding round for its clinical AI, which is used by one in four doctors in Spain. Threshold Ventures led the round, wit…

€25.5M27 Oct 2026
M&ARUMOURED

Bon Secours Nears $6bn Acquisition of Bain-Backed Surgery Partners

US hospital chain Bon Secours is nearing a $6bn takeover of Surgery Partners, a provider backed by private equity firm Bain Capital. The transaction involves a …

$6.0Bn25 Oct 2026
M&ARUMOURED

Smith & Nephew Talks to Combine with Johnson & Johnson's Orthopaedics Unit Collapsed Over Leadership Dispute

Smith & Nephew held discussions to combine its business with Johnson & Johnson's orthopaedics unit. The transatlantic talks ultimately fell apart because Smith …

23 Oct 2026
LBOSIGNED

Buyout firm EQT acquires German diagnostics group in €10.8bn deal

Buyout firm EQT has acquired Germany’s Qiagen in a take-private transaction valued at €10.8 billion. This deal represents one of the largest take-private transa…

€10.8Bn21 Oct 2026
ECMSIGNED

Inveready leads €3.5 million round for biotech Hawk Biosystems for its cancer diagnostic technology

Inveready is leading a €3.5 million funding round for Hawk Biosystems, a biotechnology company developing cancer diagnostic technology. The company also has bac…

€3.5M21 Oct 2026
M&ASIGNED

Clínicas Mi acquires a center in Tarragona and expands its Lleida hospital

The hospital group Clínicas Mi, backed by the Masfurroll family and Portobello, is investing 40 million euros. This investment covers the acquisition of Policlí…

19 Oct 2026
Debt AdvisorySIGNED

Ferrer Reports €32 Million Loss Amidst €616 Million Revenue and New Syndicated Loan

Ferrer has reported a net loss of €32 million, attributed to exceptional items, despite generating €616 million in revenue. The company also secured a new syndi…

€218M16 Oct 2026
M&APUBLISHED

Lilly Invests €156 Million to Expand Spanish Obesity Drug Production

Pharma giant Lilly is investing €156 million to increase production capacity at its Alcobendas plant in Spain for its oral obesity therapy, Orforglipron. The dr…

€156M16 Oct 2026
M&ASIGNED

Healthcare Activos Buys Two German Mental Health Clinics for €50 Million

Healthcare Activos has acquired two mental health clinics in Germany from Median. The facilities span 21,500 square meters and have a combined capacity of 250 b…

€50M15 Oct 2026
M&ASIGNED

Buenavista Acquires Tiryaq Medical Group, Entering Traumatology

Spanish venture capital firm Buenavista Equity Partners has acquired a 71.2% stake in Tiryaq Medical Group. This move marks Buenavista's increased investment in…

15 Oct 2026
M&ASIGNED

WCAS sells $2.8bn CenterWell clinic stake to BlackRock’s HPS

Whipsnade Capital Advisors (WCAS) is selling its stake in CenterWell, a network of senior primary care clinics, to BlackRock's HPS Investment Partners. The join…

$2.8Bn13 Oct 2026
M&ASIGNED

Midea Finalises Acquisition of Esaote

Midea Group has announced the finalisation of its acquisition of Esaote, a leader in medical imaging. This acquisition underscores Midea's commitment to the hea…

9 Oct 2026
M&ASIGNED

Polish pharma firm Adamed to invest €100 million in former Sanofi plant in Girona

Polish pharmaceutical company Adamed plans to invest €100 million in the former Sanofi factory located in Girona, Spain. This investment aims to double producti…

€100M8 Oct 2026
M&ASIGNED

SEPI and Vivanta administrator clash over €40 million rescue in Vitaldent sale

Spain's state holding company SEPI and the administrator of Vivanta are in dispute over €40 million related to the sale of the dental chain to Vitaldent. SEPI, …

€40M8 Oct 2026
M&ACLOSED

Ribera completes acquisition of HCB hospital group

Ribera has completed the acquisition of the HCB hospital group. This acquisition incorporates two hospitals, three medical centers, and two diagnostic imaging c…

6 Oct 2026
Debt AdvisorySIGNED

Angelini Ventures and EIB Co-lead $58 Million Series A Financing in Rouge Therapeutics

Angelini Ventures and the European Investment Bank (EIB) have co-led a $58 million Series A financing round for Rouge Therapeutics. This funding will advance th…

$58M6 Oct 2026
M&ASIGNED

ProA expands its dental implant platform with Bioner acquisition

ProA is consolidating its presence in the dental implantology sector by incorporating Bioner into the Klockner group. Following the operation, the group's sales…

5 Oct 2026
M&ARUMOURED

McKesson and CD&R Near $5bn Deal for Infusion Services Provider

McKesson and Clayton, Dubilier & Rice (CD&R) are reportedly close to a deal to acquire Option Care Health, a provider of infusion services. The transaction is v…

$5.0Bn5 Oct 2026
M&ASIGNED

Noucor buys German pharmaceuticals firm Helm

Noucor, a pharmaceutical company controlled by MCH and a group of family offices, has acquired the German firm Helm Pharmaceuticals. The combined entity anticip…

5 Oct 2026
M&APUBLISHED

Private Equity Funds Target Spanish Ambulance Sector with €2.15 Billion Investment

Private equity funds, particularly international asset managers, are investing in the Spanish ambulance sector, aiming for a return of 2.15 billion euros. This …

€2.1Bn3 Oct 2026
M&APUBLISHED

Doussinague: "Sesderma Has Capacity to Double Its Size"

The new CEO of Sesderma, Doussinague, stated that the company has the potential to double its size following the entry of JB Capital. The plan is to scale up th…

3 Oct 2026
M&ARUMOURED

MCH Negotiates Stake in World Medica

Spanish venture capital firm MCH is in negotiations to acquire a minority stake in World Medica, a medical distributor. The deal aims to expand MCH's investment…

3 Oct 2026
M&ASIGNED

Novartis signs $7.8 billion drug deal with Chinese startup

Novartis has entered into a drug deal worth $7.8 billion with a Chinese startup. The specifics of the drug or the startup were not detailed in the headline.

$7.8Bn2 Oct 2026
M&ARUMOURED

Sycamore Seeks to Break Up Walgreens Boots Alliance

Sycamore Capital Management is reportedly seeking to break up the Walgreens Boots Alliance. Further details on the specific proposals or strategy were not immed…

1 Oct 2026
M&ASIGNED

Fresenius Buys Remaining 45% Stake in mAbxience for €750 Million

Fresenius has acquired the remaining 45% stake in its biopharmaceutical subsidiary mAbxience for €750 million. This transaction creates an integrated biopharmac…

€750M1 Oct 2026
M&ASIGNED

ALK expands tablet supply partnership with Catalent

ALK has announced an expansion of its strategic tablet supply partnership with Catalent. The details of the expansion were not disclosed, but it pertains to tab…

30 Sept 2026
Debt AdvisorySIGNED

CE-Ventures Backs Aptadir Therapeutics in €40 Million Seed Round, One of Europe’s Largest in Biotech

CE-Ventures, the corporate venture capital arm of Crescent Enterprises, has invested in Aptadir Therapeutics through a €40 million seed round. This funding supp…

€40M29 Sept 2026
Debt AdvisorySIGNED

Peptomyc Secures €5.7 Million in Funding, ICF Joins Capital

Biotechnology firm Peptomyc has raised €5.7 million in a funding round, with the Catalan government's financial entity, ICF, investing €700,000. This capital in…

€5.7M29 Sept 2026
M&ASIGNED

Novo Nordisk Acquires Global Rights to Chinese Obesity Pill for $2.26 Billion

Novo Nordisk has secured global rights to an experimental obesity pill developed by China's Hengrui. The Danish company will be able to develop, manufacture, an…

$2.3Bn29 Sept 2026
M&ASIGNED

Cruinn Diagnostics, Backed by Waterland, Acquires Katalyst Diagnostics

Cruinn Diagnostics, a portfolio company of Waterland Private Equity, has acquired Katalyst Diagnostics. This move signifies Cruinn's entry into a new market.

24 Sept 2026
Debt AdvisoryPUBLISHED

Kasvu Therapeutics Raises €30 Million Series A Financing Round

Kasvu Therapeutics has announced a €30 million Series A financing round led by Hadean Ventures. The funds will be used to advance its novel TrkB potentiator int…

€30M24 Sept 2026
M&ASIGNED

Axis invests €5 million in Tucuvi Care to boost growth and international expansion

AXIS, ICO's venture capital arm, has approved a €5 million investment in Tucuvi Care, S.L., a Spanish company specializing in healthcare technology. This invest…

€5M23 Sept 2026
M&ASIGNED

Arlington-Backed AVS Bio Acquires UK Bioreagent Supplier Biorbyt

AVS Bio, a company backed by Arlington, has acquired Biorbyt, a UK-based supplier of bioreagents for life science research. Biorbyt offers a catalog of over one…

23 Sept 2026
Debt AdvisorySIGNED

ViferaXS Secures €12 Million to Advance Oncology Pipeline and Clinical Trials

ViferaXS has successfully closed a €12 million financing round, including grant funding, to advance its Phase II trial in chronic lymphocytic leukemia and expan…

€12M23 Sept 2026
Debt AdvisorySIGNED

Anaconda Biomed Raises €49 Million for Medical Technology

Anaconda Biomed has raised €49 million to fund the development of its medical technology, including product development and clinical research. The funding round…

€49M23 Sept 2026
M&ASIGNED

Telix Pharmaceuticals to acquire and merge with BlackRock-backed ITM for up to $2.35bn

Telix Pharmaceuticals is set to acquire and merge with ITM, a company backed by BlackRock, in a deal valued at up to $2.35 billion. Telix will pay an upfront ca…

$2.4Bn21 Sept 2026
M&ASIGNED

BDO advises Avior Capital on seven initial acquisitions for Humanis Care

BDO has advised Avior Capital on the completion of seven initial acquisitions for its newly formed entity, Humanis Care. Humanis Care was launched with an initi…

€50M18 Sept 2026
M&ASIGNED

1ST Biotherapeutics and SK Biopharmaceuticals Ink Global License Deal

1ST Biotherapeutics and SK Biopharmaceuticals have entered into an exclusive global license agreement for Parkinson's disease candidate '1ST-104'. The deal is v…

$314.8M17 Sept 2026
M&ASIGNED

Novo Partners with Anthropic to Accelerate Obesity Drug Development with Claude AI

Novo Nordisk is partnering with Anthropic to accelerate the development of obesity drugs using Claude AI. The pharmaceutical company aims to become the world's …

16 Sept 2026
M&ASIGNED

GSK Secures License for Chinese Cancer Drug for €637 Million

British pharmaceutical giant GSK has obtained the licensing rights for a Chinese cancer drug in a deal valued at €637 million. This agreement is part of a serie…

€637M16 Sept 2026
Debt AdvisorySIGNED

Pelayo Cortina Koplowitz Secures €154 Million from Goldman Sachs for Luxury Health Center

Pelayo Cortina Koplowitz has secured €154 million from Goldman Sachs for a luxury health center in Marbella. The total investment is expected to reach €260 mill…

€154M14 Sept 2026
M&ASIGNED

Lilly Acquires Biotech with Drug Trials in Spain

Eli Lilly has acquired a biotechnology company whose lead drug candidate is undergoing clinical trials in Spain. The acquisition was reported by elEconomista.es…

14 Sept 2026
M&ARUMOURED

GE HealthCare in talks over $1bn deal for maker of cancer scan chemicals

GE HealthCare is reportedly in negotiations to acquire Sofie Biosciences, a company specializing in cancer scan chemicals. This potential acquisition would be G…

$1.0Bn13 Sept 2026
M&ARUMOURED

CVC Faces Shareholder Revolt Over Recordati Take-Private

Private equity firm CVC is facing a shareholder revolt concerning its €10.7 billion take-private offer for Recordati. Investors are accusing CVC of pressuring t…

€10.7Bn13 Sept 2026
M&ASIGNED

Biovance Capital, Arcano Partners, and EIC Fund Invest €11 Million in Vaxdyn

Biovance Capital, Arcano Partners, and the EIC Fund have jointly invested €11 million in Vaxdyn. The funding is intended to support Vaxdyn's growth and developm…

€11M11 Sept 2026
Debt AdvisorySIGNED

CONNECTA Therapeutics Raises €3.1 Million in Funding Round Led by Clave Capital

Spanish venture capital portal reports that CONNECTA Therapeutics has secured €3.1 million in a funding round. The capital raised is intended to support Spanish…

€3.1M10 Sept 2026
M&ASIGNED

Cantabria Labs reinforces the business of its subsidiary Stangest in Tarragona

The dermatological group Cantabria Labs is boosting the expansion of its veterinary subsidiary Stangest's factory in Valls. The objective is to increase product…

9 Sept 2026
M&ASIGNED

Toscafund, Three Hills, Ares consortium agrees $1.4bn buyout of Spire Healthcare

A consortium including Toscafund, Three Hills, and Ares has agreed to a $1.4 billion buyout of Spire Healthcare. Spire Healthcare is a London-listed independent…

$1.4Bn8 Sept 2026
M&ASIGNED

Spire Healthcare accepts private equity takeover bid exceeding £1 billion

Spire Healthcare has accepted a private equity takeover offer exceeding £1 billion. This acquisition is backed by private equity.

£1.0Bn7 Sept 2026
Debt AdvisoryPUBLISHED

Vitalia to Invest €400 Million in Expansion, Postpones IPO

Spanish healthcare provider Vitalia plans to invest an additional €400 million in its expansion, aiming to reach 130 centers in Spain over the next five years. …

€400M7 Sept 2026
Debt AdvisoryCLOSED

Polyrizon Ltd. Closes $4 Million Registered Direct Offering and Private Placement

Polyrizon Ltd., a development-stage biotech company, has announced the closing of a $4.0 million registered direct offering and private placement. The funds are…

$4M4 Sept 2026
Debt AdvisorySIGNED

Tensive Secures €20 Million EIB Funding for Bioresorbable Breast Implant Commercialization

Tensive has received €20 million in funding from the European Investment Bank (EIB) to support the commercialization of its bioresorbable breast implant technol…

€20M3 Sept 2026
HealthcareTMTInfrastructureEnergy & RenewablesFinancial ServicesConsumerIndustrialsReal Estate
HomeAnalysisRankingsLearn